English
Uterine Artery Embolization Treatment Hospital in Bangalore

Uterine Fibroid Embolization

Uterine Artery Embolization Treatment in Broadway

A minimally invasive radiological technique called uterine fibroid embolisation (UFE) is used to treat symptomatic uterine fibroids, which are benign tumours in the uterus. Under UFE, which is performed by an interventional radiologist, a catheter is inserted into the uterine arteries via a tiny incision in the wrist or groin. The fibroids are then injected with embolic agents, which are usually tiny particles, to cut off their blood supply. This causes the fibroids to shrink and relieve symptoms including pelvic pressure, painful menstruation, and excessive bleeding. Compared to conventional surgical procedures like Hysterectomy or Myomectomy, Uterine Artery Embolization treatment in Broadway has several advantages. It is advantageous for women who want to retain their fertility since it is less invasive, requires less time to recover from, and protects the uterus. Most patients are released the same day or within 24 hours after the surgery, which usually takes one to two hours. Pain control and post-procedural care monitoring for problems like ischemia or infection are included. UFE is regarded as a safe, effective option for women seeking non-surgical treatment of uterine fibroids, with high success rates for symptom reduction.

FAQ's

The minimally invasive, image-guided treatment known as "uterine fibroids embolisation" (UFE) stops the blood supply to uterine fibroids. By injecting embolic substances into the uterine arteries using a catheter, symptoms such as severe bleeding and pelvic discomfort are relieved, and fibroids decrease. Compared to surgery, UFE is less intrusive, maintains the uterus, recovers more quickly, and relieves symptoms quite often. Although they are uncommon, potential side effects include non-target embolisation and infection.
 

Women who want a minimally invasive procedure and who want to keep their uterus intact and have symptomatic fibroids that cause heavy bleeding, pelvic discomfort, or urinary problems addressed are good candidates for Uterine Fibroid Embolisation (UFE). Those with several or big fibroids, those who want a speedy recovery, and those who are not good candidates for surgery can all benefit from UFE. Pregnancy, some forms of fibroid, active pelvic infections, and severe sensitivities to contrast media are among the excluded.
 

Post-embolisation syndrome, infection, non-target embolisation, reperfusion syndrome, and uterine necrosis are some of the side effects that may occur. Long-term risks could include fibroid ejection, delayed menopause, adverse reactions to contrast media, and pelvic discomfort or recurrence. Healthcare providers must educate patients about these risks and implement the necessary precautions to ensure safe outcomes.

Imaging, such as ultrasound or MRI, helps in pre-procedure planning during UFE by determining the size and location of the fibroids. Delivery of embolic agents to uterine arteries and catheter navigation is guided by real-time fluoroscopy imaging. Using contrast dye (angiography), blood flow is visualised to help locate the arteries that supply fibroids. Post-procedure imaging identifies problems such as embolisation or uterine necrosis and evaluates the effectiveness of therapy. Precise treatment and ideal results are guaranteed by this combined strategy.
 

UFE uses a variety of embolic agents, such as microspheres, spherical embolic agents, tris-acryl gelatin microspheres (TAGMs), gelatin sponge particles, and polyvinyl alcohol (PVA) particles. These substances, when injected into uterine arteries, stop the blood supply to fibroids, causing ischaemia and consequent shrinking. Every medication operates differently, aiming to maximise therapeutic results while reducing side effects. The decision is based on patient-specific variables and fibroid features.
 

Painkillers are used to treat patients' modest discomfort, weariness, and pelvic cramps after uterine fibroids are embossed. Initial vaginal spot and discharge are possible. Days later, light activities are resumed; intense exertion is avoided. Usually, symptom alleviation takes place in a few weeks to months. Frequent follow-up visits track progress and evaluate the effectiveness of treatment. For early intervention, patients should report any troubling symptoms as soon as possible. All things considered, UFE provides notable symptom alleviation and enhanced quality of life.
 

Pelvic discomfort and heavy menstrual flow are two symptoms of uterine fibroids that are effectively treated with UFE. 70% to over 90% of patients have success, and most have symptom relief in a matter of weeks or months. For the best results, careful patient selection and follow-up treatment are essential. Many women choose UFE because it provides equivalent symptom relief to surgery, has fewer complications, and requires less time to recover from.
 

After undergoing UFE, patients are monitored, symptoms are monitored, medicines are managed, and food and activity restrictions are followed. Frequent follow-up consultations measure the effectiveness of treatment and the extent of healing; imaging investigations measure the reduction in fibroid size and identify any problems. Patient education on menstrual changes, reproductive concerns, and lifestyle improvements is complemented by long-term monitoring, which guarantees the best possible results. This all-inclusive strategy reduces problems and improves recovery following UFE.

Home Broadway Specialities Radiology Uterine-fibroid-embolization

Appointment
Health Check
Contact Us
review icon
Review Us
Call Us